Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07102849) titled 'Molecular and Clinical Analysis of Bone Marrow Failure: A Secondary Research Study' on Aug. 2.
Study Type: Observational
Primary Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Condition:
Bone Marrow Failure Disorders
VEXAS Syndrome
Hemoglobinurea, Paroxysmal
Myelodysplastic Syndromes
Bone Marrow Diseases
Recruitment Status: Not recruiting
Date of First Enrollment: August 27, 2025
Target Sample Size: 1400
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07102849
Published by HT Digital Content Services with permission from Health Daily Digest....